AHR (AHR) EVP Foster vests RSUs, withholds tax shares and sells 2,000

Rhea-AI Filing Summary

American Healthcare REIT EVP, GC & Secretary Mark E. Foster reported compensation-related stock activity and a small share sale. On March 25, 2026, 11,108 restricted stock units converted into the same number of common shares, while 5,652 shares were withheld to cover tax obligations.

He also sold 2,000 common shares at $48.55 per share in an open-market transaction executed under a pre-arranged Rule 10b5-1 trading plan. Following these moves, Foster directly holds 56,121 shares of common stock and received a new grant of 6,510 time-based RSUs that will vest in equal parts from 2027 through 2029.

Insider Trade Summary 10b5-1

Net Seller: 2,000 shares ($97,100)

Net Sell 8 txns

Insider Foster Mark E.

Role EVP, GC & Secretary

Sold 2,000 shs ($97K)

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Unit	7,435	$0.00	--
Exercise	Restricted Stock Unit	3,673	$0.00	--
Grant/Award	Restricted Stock Unit	6,510	$0.00	--
Exercise	Common Stock	7,435	$0.00	--
Tax Withholding	Common Stock	3,783	$48.25	$183K
Exercise	Common Stock	3,673	$0.00	--
Tax Withholding	Common Stock	1,869	$48.25	$90K
Sale	Common Stock	2,000	$48.55	$97K

Holdings After Transaction: Restricted Stock Unit — 7,436 shares (Direct); Common Stock — 60,100 shares (Direct)

Footnotes (1)

1. Each restricted stock unit ("RSU") converts into one share of the Issuer's common stock. Shares withheld by the Issuer to satisfy the Reporting Person's tax obligations associated with the vesting of time-based RSUs on March 25, 2026. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025. On March 25, 2024, the Issuer awarded the Reporting Person 22,306 time-based RSUs. The RSUs vest ratably on March 25, 2025, 2026 and 2027 (subject to continuous employment through each vesting date). On March 25, 2025, the Issuer awarded the Reporting Person 11,021 time-based RSUs. The RSUs vest ratably on March 25, 2026, 2027 and 2028 (subject to continuous employment through each vesting date). On March 25, 2026, the Issuer awarded the Reporting Person 6,510 time-based RSUs. The RSUs will vest ratably on March 10, 2027, 2028 and 2029 (subject to continuous employment through each vesting date).

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

X

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Foster Mark E.

(Last) (First) (Middle)

C/O AMERICAN HEALTHCARE REIT, INC.

18191 VON KARMAN AVE., STE. 300

(Street)

IRVINE CALIFORNIA 92612

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
American Healthcare REIT, Inc. [ AHR ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

	Director		10% Owner
X	Officer (give title below)		Other (specify below)
	EVP, GC & Secretary

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
03/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	03/25/2026		M		7,435	A	(1)	60,100	D
Common Stock	03/25/2026		F		3,783(2)	D	$48.25	56,317	D
Common Stock	03/25/2026		M		3,673	A	(1)	59,990	D
Common Stock	03/25/2026		F		1,869(2)	D	$48.25	58,121	D
Common Stock	03/25/2026		S(3)		2,000	D	$48.55	56,121	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Unit	(1)	03/25/2026		M			7,435	(4)	(4)	Common Stock	7,435	$0	7,436	D
Restricted Stock Unit	(1)	03/25/2026		M			3,673	(5)	(5)	Common Stock	3,673	$0	7,348	D
Restricted Stock Unit	(1)	03/25/2026		A		6,510		(6)	(6)	Common Stock	6,510	$0	6,510	D

Explanation of Responses:

1. Each restricted stock unit ("RSU") converts into one share of the Issuer's common stock.

2. Shares withheld by the Issuer to satisfy the Reporting Person's tax obligations associated with the vesting of time-based RSUs on March 25, 2026.

3. This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 19, 2025.

4. On March 25, 2024, the Issuer awarded the Reporting Person 22,306 time-based RSUs. The RSUs vest ratably on March 25, 2025, 2026 and 2027 (subject to continuous employment through each vesting date).

5. On March 25, 2025, the Issuer awarded the Reporting Person 11,021 time-based RSUs. The RSUs vest ratably on March 25, 2026, 2027 and 2028 (subject to continuous employment through each vesting date).

6. On March 25, 2026, the Issuer awarded the Reporting Person 6,510 time-based RSUs. The RSUs will vest ratably on March 10, 2027, 2028 and 2029 (subject to continuous employment through each vesting date).

	/s/ MARK E. FOSTER	03/27/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did AHR executive Mark E. Foster report in this Form 4 filing?

Mark E. Foster, EVP, GC & Secretary of AHR, reported RSU vesting, tax-related share withholding, a small open-market sale of 2,000 shares, and receipt of a new 6,510-share RSU grant as part of his equity compensation.

How many American Healthcare REIT shares does Mark E. Foster now hold?

After these transactions, Mark E. Foster directly holds 56,121 shares of AHR common stock. This reflects RSU conversions into shares, shares withheld to pay taxes, and a 2,000-share open-market sale disclosed in the Form 4 filing.

What RSU activity did AHR disclose for Mark E. Foster on March 25, 2026?

On March 25, 2026, 11,108 RSUs held by Mark E. Foster converted into an equal number of common shares. As part of this vesting, 5,652 shares were withheld by the company to satisfy tax obligations associated with the RSU vesting.

Did Mark E. Foster sell any American Healthcare REIT shares in this filing?

Yes. Mark E. Foster sold 2,000 shares of AHR common stock at $48.55 per share. According to a footnote, this open-market sale was executed under a Rule 10b5-1 trading plan adopted on December 19, 2025.

Was the AHR insider stock sale done under a Rule 10b5-1 plan?

Yes. The Form 4 states the 2,000-share sale by Mark E. Foster was conducted under a Rule 10b5-1 trading plan adopted on December 19, 2025, indicating the trade was pre-arranged rather than a discretionary timing decision.

What new restricted stock units did AHR grant to Mark E. Foster?

On March 25, 2026, AHR granted Mark E. Foster 6,510 time-based RSUs. According to the filing, these units will vest in equal installments on March 10, 2027, 2028, and 2029, subject to his continued employment through each vesting date.